Functional cure of HIV-1 infection in an exceptional elite controller: a case report

José M. Benito(Hospital Universitario Rey Juan Carlos), Norma Rallón(Hospital Universitario Rey Juan Carlos), Katie Fisher(Westmead Institute), María J. Buzón(Universitat Autònoma de Barcelona), Juan Carlos López-Bernaldo(Hospital General Universitario Gregorio Marañón), Sarah Jane Palmer(Westmead Institute), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Vicente Estrada(Instituto de Salud Carlos III), Andrea Pereyra-Casanova(Westmead Institute), Alfonso Cabello(Hospital Universitario Fundación Jiménez Díaz)
The Lancet HIV
November 5, 2025
10.1016/s2352-3018(25)00233-4
Cited by 4

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|The Lancet|2006|343
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
|Mucosal Immunology|2014|332